Crohn's disease Treatment Market - Top Companies and Manufacturers

  • Report ID: 3004
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Crohn's Disease Treatment Landscape

    • Johnson & Johnson Services Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Allergan
    • AbbVie Inc.
    • Bayer AG
    • Amgen Inc.
    • Takeda Pharmaceutical Company Limited
    • UCB S.A.
    • Ferring B.V.
    • Eli Lilly Company
    • Hoffman-La Roche
    • Bristol-Myers Squib

Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 3004
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidence of bowel disorders such as Crohn’s disease due to lifestyle changes and increasing awareness about Crohn’s disease, and the availability of treatments.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

High cost of treatment and delay in diagnosis are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about chron’s disease.

The major players dominating the chron’s disease treatment market are Pfizer Inc., Allergan, AbbVie Inc., Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Ferring B.V., Eli Lilly Company, Hoffman-La Roche, Bristol-Myers Squibb among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample